SEARCH

SEARCH BY CITATION

References

  • Antin, J.H. & Ferrara, J.L.M. (1992) Cytokine dysregulation and acute graft-versus-host disease. Blood, 80, 29642968.
  • Auffermann-Gretzinger, S., Lossos, I.S., Vayntrub, T.A., Leong, W., Grumet, F.C., Blume, K., Stockerl-Goldstein, K.E., Levy, R. & Shizuru, J.A. (2002) Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood, 99, 14421448.
  • Banchereau, J. & Steinmann, R.M. (1998) Dendritic cells and the control of immunity. Nature, 392, 245252.
  • Chan, G.W., Gorgun, G., Miller, K.B. & Foss, F.M. (2003) Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biology of Blood and Marrow Transplantation, 9, 170176.
  • Childs, R., Clave, E., Conetentin, N., Jayasekera, D., Hensel, N., Leitman, S., Read, E.J., Carter, C., Bahceci, E., Young, N.S. & Barrett, A.J. (1999) Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood, 94, 32343241.
  • Clark, F.J., Freeman, L., Dzionek, A., Schmitz, J., McMullan, D., Simpson, P., Mason, J., Mahendra, P., Craddock, C., Griffiths, M., Moss, P.A. & Chakraverty, R. (2003) Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease. Transplantation, 75, 221225.
  • Ferrara, J.L.M. (2000) Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. Journal of Hematotherapy and Stem Cell Research, 9, 299306.
  • Gaiger, A., Mannhalter, C., Hinterberger, W., Haas, O., Marosi, C., Kier, P., Eichinger, S. & Lechner, K. (1991) Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene. Annals of Hematology, 63, 227228.
  • Giralt, S., Estey, E., Albitar, M., Van Besien, K., Rondon, G., Anderlini, P., O'Brian, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Korbling, M., Keating, M., Kantarjian, H. & Champlin, R. (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood, 89, 45314536.
  • Giralt, S., Thall, P.F., Khouri, I., Wang, X., Braunschweig, I., Ippolitti, C., Claxton, D., Donato, M., Bruton, J., Cohen, A., Davis, M., Andersson, B.S., Anderlini, P., Gajewski, J., Kornblau, S., Andreeff, M., Przepiorka, D., Ueno, N.T., Molldrem, J. & Champlin, R. (2001) Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood, 97, 631637.
  • Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neimann, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295301.
  • Gooley, T.A., Leisenring, W., Crowley, J. & Storer, B.E. (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine, 18, 695706.
  • Gratwohl, A., Brand, R., Apperley, J., Van Biezen, A., Bandini, G., Devergie, A., Schattenberg, A., Frassoni, F., Guglielmi, C., Iacobelli, S., Michalle, M., Kolb, H.J., Ruutu, T. & Niederwieser, D. for the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (2002) Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood, 100, 38773886.
  • Hart, D.N.J. (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 90, 32453287.
  • Huber, C., Fink, U., Leibold, W., Schmalzl, F., Peterson, P.A. & Klareskog, L. (1981) The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR. Journal of Immunology, 127, 726731.
  • Huss, R., Deeg, H.J., Gooley, T., Bryant, E., Leisenring, W., Clift, R., Buckner, C.D., Martin, P., Storb, R. & Appelbaum, F.R. (1996) Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplantation, 18, 767776.
  • Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • Khouri, I.F., Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brian, S., Giralt, S., Ippoliti, C., Von Wolff, B., Gajewski, J., Donato, M., Claxton, D., Ueno, N., Andersson, B., Gee, A. & Champlin, R. (1998) Transplant-lite: induction of graft-versus-malignancy used fludarabine-based non-ablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. Journal of Clinical Oncology, 16, 28172824.
  • Klangsinsirikul, P., Carter, G.I., Byrne, J.L., Hale, G. & Russel, N.H. (2002) Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood, 99, 25862591.
  • Van Leeuwen, J.E., Van Tol, M.J., Joosten, A.M., Wijnen, J.T., Verweij, P.J., Khan, P.M. & Vossen, J.M. (1994) Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or conditioning regimen, but is not associated with an increased risk of relapse. Blood, 83, 30593067.
  • MacDonald, K.P.A., Munster, D.J., Clark, G.J., Dzionek, A., Schmitz, J. & Hart, D.N.J. (2002) Characterization of human blood dendritic cell subsets. Blood, 100, 45124520.
  • Mackinnon, S., Barnett, L., Heller, G. & O'Reilly, R.J. (1994) Minimal residual disease is more common in patients who have a mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood, 83, 34093416.
  • McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E.D., Georges, G.E., Grumet, F.C., Kiem, H.P. & Torok-Storb, B., Yu, C., Blume, K.G. & Storb, R.F. (2001) Hematopoietic stem cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, 33904000.
  • Mattsson, J., Uzunel, M., Remberger, M. & Ringdén, O. (2001) T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation, 71, 433439.
  • Mehling, A., Rabbe, S., Voskort, M., Schwarz, T., Luger, T.A. & Beissert, S. (2000) Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. Journal of Immunology, 165, 23742381.
  • Monti, P., Allavena, P., Di Carlo, V. & Piemonti, L. (2003) Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. International Immunopharmacology, 3, 189196.
  • Morse, M.A., Rizzieri, D., Stenzel, T.T., Hobeika, A.C., Vredenburgh, J.J., Chao, N.J., Clay, T.M., Mosca, P.J. & Lyerly, H.K. (2002) Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants. Journal of Hematotherapy and Stem Cell Research, 11, 659668.
  • Nachbaur, D., Eibl, B., Kropshofer, G., Meister, B., Mitterschiffthaler, A., Schennach, H., Fischer, G., Kopp, M., Gunsilius, E. & Gastl, G. (2002) In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation. Journal of Hematotherapy and Stem Cell Research, 11, 731737.
  • Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D. & Schuler, G. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. Journal of Immunological Methods, 196, 137151.
  • Shlomchik, W.D., Couzens, M.S., Tang, C.B., McNiff, J., Robert, M.E., Liu, J., Shlomchik, M.J. & Emerson, S.G. (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science, 285, 412415.
  • Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.F., Hackman, R., Tsoi, M.S., Storb, R. & Storb, R. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204211.
  • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 765763.
  • Sullivan, K.M., Weiden, P.L., Storb, R., Witherspoon, R.P., Fefer, A., Fisher, L., Buckner, C.D., Anasetti, C., Appelbaum, F.R., Badger, C., Beatty, P., Bensinger, W., Berenson, R., Bigelow, C., Cheever, M.A., Clift, R., Deeg, H.J., Doney, K., Greenberg, P., Hansen, J.A., Hill, R., Loughran, T., Martin, P., Neiman, P., Petersen, F.B., Sanders, J., Singer, J., Stewart, P. & Thomas, E.D. (1989) Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood, 73, 17201728.
  • Wekerle, T. & Sykes, M. (2001) Mixed chimerism and transplantation tolerance. Annual Reviews of Medicine, 52, 353370.